echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Chest: Proton pump inhibitors in idynogenic pulmonary fibrosis efficacy analysis.

    Chest: Proton pump inhibitors in idynogenic pulmonary fibrosis efficacy analysis.

    • Last Update: 2020-09-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Gastroesophedic reflow disease is a common combination of idynic pulmonary fibrosis (IPF) that may promote its progress.
    such as proton pump inhibitors (PPI) have been seen as potential treatments for IPF.
    a recent study published in the authoritative journal Chest in the field of respiratory medicine, which aims to clarify whether the use of PPI treatment in IF patients reduces all-cause mortality, respiratory-related mortality and respiratory-related hospitalizations.
    used the UK Clinical Practice Study data chain to determine the queue of patients diagnosed with IF between 2003 and 2016.
    used the Cox model to estimate the risk ratio (HR) and 95% confidence interval (CI) for death and respiratory-related hospitalizations, and to correct the information review with a weighted inverse probability.
    in the IF patient queue, there were 1,852 PPI users and 1,852 matching non-users with a medium survival of 2.8 years (26.7 per 100 patients per year).
    compared to those who did not take PPI, the HR mortality rate for PPI takers was 1.07 (95% CI was 0.94-1.22).
    HR for respiratory-related mortality was 1.10 (95% CI was 0.94-1.28) and HR for respiratory-related hospitalization was 1.00 (95% CI was 0.86-1.16).
    , in this large study of IPAF patients, PPI was not associated with lower mortality or hospitalization rates.
    benefits of taking PPI may not be as effective as some studies recommend.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.